Employer Insights
Filter News
Found 228 articles
-
As companies prioritize in-person work, many have begun to do more to incentivize a reluctant workforce to come into the office. -
M2GEN Rebrands to Aster Insights
4/14/2023
M2GEN today announced it is rebranding, changing the company's name to Aster Insights™.
-
Proximity bias, a term that describes how managers tend to favor those they see in person, may force remote and hybrid workers to work harder to keep up with their in-person counterparts. -
If biopharma-focused co-working spaces continue to catch on, they could expand job opportunities for those outside of the typical hot spots.
-
Does Your Alma Mater Really Matter?
2/22/2023
Some consider a candidate’s alma mater to be the most important factor in the hiring process. But how much does a life science candidate’s alma mater really matter? In short–it depends. -
New York City employers who use Artificial Intelligence (AI) tools in hiring will soon be subject to new regulations requiring them to notify candidates when using the technology. -
Finding a mentor who can serve as a guide for one’s career is a goal for many young professionals. But reverse mentorship can be just as beneficial, as both parties stand to benefit.
-
Cambrian Biopharma announced that its latest pipeline company, Isterian Biotech, has emerged from stealth to develop first-in-class medicines to tackle aging. -
Amarin Corporation wrestled with activist investor Sarissa Capital Management as the latter tried to replace Amarin’s current board of directors with its representatives.
-
Successfully managing Gen Z employees in the workplace requires knowing about their distinctive traits and the factors that set them apart. -
The past two years have seen a considerable shift towards remote work, but now that the pandemic is waning, BioSpace has compiled relevant data on remote work to see if it's here to stay. -
Those who work in the biopharma industry often see more setbacks than successes. To understand how to overcome failures, BioSpace spoke with two experts on coping with setbacks and staying positive. -
Karuna Therapeutics appointed Bill Meury as its new president and chief executive officer, succeeding its current head, Steve Paul. -
Many executives haven’t established their personal brands or even know that they need one. BioSpace spoke with top executives in the field to learn about the importance of a personal executive brand. -
Teva Pharmaceuticals has found its new president and CEO. Effective Jan. 1, 2023, Richard Francis will take the company's reins as Kåre Schultz retires. -
With the Thanksgiving season upon us, there are many reasons for biopharma and life sciences companies to say thanks, including for new leaders. -
While Biogen and Seagen made the biggest C-suite splashes this week, other companies across the biopharma industry also bolstered their leadership teams with new talent. -
GSK and Sanofi veteran Christopher A. Viebacher will take over as chief executive officer for Biogen. He replaces Michel Vounatsos, whose departure was announced in May. -
The executive shuffle continues across the biopharma industry as companies shore up leadership needs with these Movers & Shakers. -
A new municipal law took effect Tuesday in New York City, requiring companies with four or more employees to include a specific pay range in every job posting.